Clinical Trial: Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Shared Genetic Susceptibility in CBD and Sarcoidosis

Brief Summary: Granulomatous lung diseases are diseases in which inflamed clusters of white cells, known as granulomas, form in lung tissue. Chronic beryllium disease (CBD) and sarcoidosis are two granulomatous diseases that share similar clinical symptoms, physiological changes in the lungs, and immune responses to the disease. Genetic variations may make some people more susceptible to developing CBD or sarcoidosis. This study will identify common genetic regions associated with increased risk of developing the granulomatous diseases CBD and sarcoidosis.